glp 1 agonist cardiovascular outcomes GLP-1 Receptor Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes Beyond GLP1: modulating multiple nutrient-stimulated
Description
GLP-1 medications are a game changer for weight loss, but have serious health concerns
Find out everything about this - if its true and worth all the hype.
Clinical trial data shows a 5-10 BPM increase driven by the glucagon receptor
For professionals in pharma, clinical research, and regulatory affairs, this space is evolving fastand full of opportunity
GLP-1R agonist 2 has the potential for research in metabolic diseases such as type 2 diabetes and obesity
